The Good News: no antibodies. The bad news: now what?

I think it is great that Anne Peters has started to discuss this. She is considered by many to be a thought leader. But she still misses the boat. We already know that 10-15% of T1s (T1s that we have "diagnosed" already) test negative for antibodies. What really irks me is that a T1 diagnosis (whether autoimmune or "other") should be made based on some criteria. And the first criteria she uses is weight. Huh? How does that make sense. And then we argue that patients that move to insulin (and control their blood sugar better) have better outcomes. Of course! That is true for all diabetics. Instead, Dr. Peters will see a patient like me with a BMI of 25.5 and place us in a box labelled T2. We won't get tested for antibodies, we won't get tested for a c-peptide. When we spend so much money running stupid useless cholesterol tests, why can't we run a c-peptide?

I want doctors to treat the "condition" not the "label." In my case as in MaximJ's case, a low c-peptide should be all that is needed to guide treatment.

2 Likes